“versant-ventures” Archives

in
Entry Author Date Location
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
Passage Bio’s IPO Raises $216M to Fund Gene Therapy Studies 02/28/20 National
Coda Bio Acquires Drug Candidates to Pair With Engineered Receptors 02/06/20 San Francisco
Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic 02/03/20 New York
Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D 01/30/20 Boston
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies 12/19/19 New York
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease 08/22/19 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic 04/30/19 San Diego
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray 02/26/19 New York
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again 02/14/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Black Diamond Gets $85M for Cancer Drugs R&D and New Cambridge HQ 01/10/19 Boston
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
Versant Ventures Unveils Two New Biotech Funds Totaling $700M 12/17/18 San Francisco
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Black Diamond Emerges with $20M, Aiming for Cancer’s Hidden Targets 12/11/18 San Francisco
CEOs and Scientific Founders: Tips for a Long and Successful Marriage 11/13/18 New York
In New York, Gotham Starts Up With $54M for RNA-Modifying Drugs 10/10/18 New York
Page 1 of 10 next page »